AnnexinA5 renders dead tumor cells immunogenic—implications for multimodal cancer therapies

References

• Apte, R. N., and Voronov, E. 2008. Is interleukin-1 a good or bad “guy” in tumor immunobiology and immunotherapy? Immunol. Rev. 222:222–241.
   PubMed Web of Science ®Google Scholar
• Bianchi, M. E., and Manfredi, A. 2004. Chromatin and cell death. Biochim. Biophys. Acta 1677:181–186.
   PubMed Web of Science ®Google Scholar
• Bondanza, A., Zimmermann, V. S., Dell’Antonio, G., Cin, E. D., Balestrieri, G., Tincani, A., Amoura, Z., Piette, J. C., Sabbadini, M. G., Rovere-Querini, P., and Manfredi, A. A. 2004a. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum. 50:1549–1560.
   PubMed Web of Science ®Google Scholar
• Bondanza, A., Zimmermann, V. S., Rovere-Querini, P., Turnay, J., Dumitriu, I. E., Stach, C. M., Voll, R. E., Gaipl, U. S., Bertling, W., Poschl, E., Kalden, J. R., Manfredi, A. A., and Herrmann, M. 2004b. Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J. Exp. Med. 200:1157–1165.
   PubMed Web of Science ®Google Scholar
• Bottcher, A., Gaipl, U. S., Furnrohr, B. G., Herrmann, M., Girkontaite, I., Kalden, J. R., and Voll, R. E. 2006. Involvement of phosphatidylserine, αvβ3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. Arthritis Rheum. 54:927–938.
   PubMed Web of Science ®Google Scholar
• Brachvogel, B., Dikschas, J., Moch, H., Welzel, H., von der Mark, K., Hofmann, C., and Poschl, E. 2003. Annexin A5 is not essential for skeletal development. Mol. Cell. Biol. 23:2907–2913.
   PubMed Web of Science ®Google Scholar
• Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., and Henson, P. M. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit pro-inflammatory cytokine production through autocrine/paracrine mechanisms involving TGFβ, PGE2, and PAF. J. Clin. Invest. 101:890–898.
   PubMed Web of Science ®Google Scholar
• Ferrara, T. A., Hodge, J. W., and Gulley, J. L. 2009. Combining radiation and immunotherapy for synergistic anti-tumor therapy. Curr. Opin. Mol. Ther. 11:37–42.
   PubMed Web of Science ®Google Scholar
• Frey, B., Munoz, L. E., Pausch, F., Sieber, R., Franz, S., Brachvogel, B., Poschl, E., Schneider, H., Rodel, F., Sauer, R., Fietkau, R., Herrmann, M., and Gaipl, U. S. 2009. The immune reaction against allogeneic necrotic cells is reduced in AnnexinA5 knock out mice whose macrophages display an anti-inflammatory phenotype. J. Cell. Mol. Med. 13:1391–9.
   PubMed Web of Science ®Google Scholar
• Gaipl, U. S., Brunner, J., Beyer, T. D., Voll, R. E., Kalden, J. R., and Herrmann, M. 2003. Disposal of dying cells: a balancing act between infection and autoimmunity. Arthritis Rheum. 48:6–11.
   PubMed Web of Science ®Google Scholar
• Gaipl, U. S., Sheriff, A., Franz, S., Munoz, L. E., Voll, R. E., Kalden, J. R., and Herrmann, M. 2006. Inefficient clearance of dying cells and autoreactivity. Curr. Topics Microbiol. Immunol. 305:161–176.
   PubMed Web of Science ®Google Scholar
• Gaipl, U. S., Munoz, L. E., Rodel, F., Pausch, F., Frey, B., Brachvogel, B., von der Mark, K., and Poschl, E. 2007. Modulation of the immune system by dying cells and the phosphatidylserine-ligand annexin A5. Autoimmunity 40:254–259.
   PubMed Web of Science ®Google Scholar
• Green, D.R., Ferguson, T., Zitvogel, L., and Kroemer, G. 2009. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9:353–363.
   PubMed Web of Science ®Google Scholar
• Grundmann, U., Abel, K. J., Bohn, H., Lobermann, H., Lottspeich, F., and Kupper, H. 1988. Characterization of cDNA encoding human placental anticoagulant protein (PP4): homology with the lipocortin family. Proc. Natl. Acad. Sci. USA 85:3708–3712.
   PubMed Web of Science ®Google Scholar
• Hanley, P. J., Musset, B., Renigunta, V., Limberg, S. H., Dalpke, A. H., Sus, R., Heeg, K. M., Preisig-Muller, R., and Daut, J. 2004. Extracellular ATP induces oscillations of intracellular Ca2+ and membrane potential and promotes transcription of IL-6 in macrophages. Proc. Natl. Acad. Sci. USA 101:9479–9484.
   PubMed Web of Science ®Google Scholar
• Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., and Kalden, J. R. 1998. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41:1241–1250.
   PubMed Web of Science ®Google Scholar
• Kono, H., and Rock, K. L. 2008. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8:279–289.
   PubMed Web of Science ®Google Scholar
• Korn, A., Frey, B., Sheriff, A., Gaipl, U. S., Franz, S., Meyer-Pittroff, R., Bluemelhuberh, G., and Herrmann, M. 2004. High hydrostatic pressure-inactivated human tumor cells preserve their immunogenicity. Cell. Mol. Biol. (Noisy-le-grand) 50:469–477.
   PubMed Web of Science ®Google Scholar
• Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., Hengartner, M., Knight, R. A., Kumar, S., Lipton, S.A., Malorni, W., Nunez, G., Peter, M. E., Tschopp, J., Yuan, J., Piacentini, M., Zhivotovsky, B., and Melino, G. 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16:3–11.
   PubMed Web of Science ®Google Scholar
• Krysko, D. V., and Vandenabeele, P. 2008. From regulation of dying cell engulfment to development of anti-cancer therapy. Cell Death Differ. 15:29–38.
   PubMed Web of Science ®Google Scholar
• Lauber, K., Blumenthal, S. G., Waibel, M., and Wesselborg, S. 2004. Clearance of apoptotic cells: getting rid of the corpses. Mol. Cell. 14:277–287.
   PubMed Web of Science ®Google Scholar
• Obeid, M., Panaretakis, T., Joza, N., Tufi, R., Tesniere, A., van Endert, P., Zitvogel, L., and Kroemer, G. 2007. Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis. Cell Death Differ. 14:1848–1850.
   PubMed Web of Science ®Google Scholar
• Reutelingsperger, C. P., Hornstra, G., and Hemker, H. C. 1985. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur. J. Biochem. 151:625–629.
   PubMedGoogle Scholar
• Ronchetti, A., Rovere, P., Iezzi, G., Galati, G., Heltai, S., Protti, M.P., Garancini, M.P., Manfredi, A.A., Rugarli, C., and Bellone, M. 1999. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J Immunol. 163:130–136.
   PubMed Web of Science ®Google Scholar
• Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423–434.
   PubMed Web of Science ®Google Scholar
• Schildkopf, P., Holmer, R., Sieber, R., Ott, O. J., Janko, C., Mantel, F., Frey, B., Fietkau, R., and Gaipl, U. S. 2009. Hyperthermia in combination with X-irradiation induces inflammatory forms of cell death. Autoimmunity 42:311–313.
   PubMed Web of Science ®Google Scholar
• Shanker, A., and Sayers, T. 2007. Sensitizing tumor cells to immune-mediated cytotoxicity. Adv. Exp. Med. Biol. 601:163–171.
   PubMed Web of Science ®Google Scholar
• Shi, Y., Evans, J. E., and Rock, K. L. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521.
   PubMed Web of Science ®Google Scholar
• Shurin, G. V., Tourkova, I. L., and Shurin, M. R. 2008. Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells. J. Immunother. 31:491–499.
   PubMed Web of Science ®Google Scholar
• Shurin, M. R., Potapovich, A. I., Tyurina, Y. Y., Tourkova, I. L., Shurin, G. V., and Kagan, V. E. 2009. Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer. Cancer Res. 69:2487–2496.
   PubMed Web of Science ®Google Scholar
• Stach, C. M., Turnay, X., Voll, R. E., Kern, P. M., Kolowos, W., Beyer, T. D., Kalden, J. R., and Herrmann, M. 2000. Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice. Cell Death Differ. 7:911–915.
   PubMed Web of Science ®Google Scholar
• Tesniere, A., Apetoh, L., Ghiringhelli, F., Joza, N., Panaretakis, T., Kepp, O., Schlemmer, F., Zitvogel, L., and Kroemer, G. 2008. Immunogenic cancer cell death: a key-lock paradigm. Curr. Opin. Immunol. 20:504–511.
   PubMed Web of Science ®Google Scholar
• Umansky, V., Abschuetz, O., Osen, W., Ramacher, M., Zhao, F., Kato, M., and Schadendorf, D. 2008. Melanoma-specific memory T-cells are functionally active in Ret transgenic mice without macroscopic tumors. Cancer Res. 68:9451–9458.
   PubMed Web of Science ®Google Scholar
• Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled Annexin V. J. Immunol. Meth. 184:39–51.
   PubMed Web of Science ®Google Scholar
• Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., and Girkontaite, I. 1997. Immunosuppressive effects of apoptotic cells. Nature 390:350–351.
   PubMed Web of Science ®Google Scholar
• Wang, E., Monaco, A., Monsurro, V., Sabatino, M., Pos, Z., Uccellini, L., Wang, J., Worschech, A., Stroncek, D. F., and Marincola, F. M. 2009. Anti-tumor vaccines, immunotherapy and the immunological constant of rejection. IDrugs 12:297–301.
   PubMed Web of Science ®Google Scholar
• Zitvogel, L., Apetoh, L., Ghiringhelli, F., Andre, F., Tesniere, A., and Kroemer, G. 2008. The anticancer immune response: indispensable for therapeutic success? J. Clin. Invest. 118:1991–2001.
   PubMed Web of Science ®Google Scholar